Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new international association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary lung adenocarcinoma classification

Journal of Thoracic Oncology

Volumn 6, Issue 9, 2011, Pages 1496-1504

  Russell, Prudence A ^a   Wainer, Zoe ^a,b   Wright, Gavin M ^a,b,c   Daniels, Marissa ^c   Conron, Matthew ^c   Williams, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Acinar; Lepidic; Micropapillary; Mucinous; Papillary; Solid with mucin

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EXAMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNATHIA;

EID: 80052264344     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318221f701     Document Type: Article

References (31)

1. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-299. (Pubitemid 41379403)
2. Travis WD, Colby TV, Corrin B, et al. In collaboration with Sobin LH and pathologists from 14 countries. World Health Organization International Histological Classification of Lung Tumours. Histological Typing of Lung and Pleural Tumors, 3rd Ed. Berlin: Springer-Verlag, 1999.
3. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995;75: 2844-2852.
4. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. World Health Organisation Classification of tumours. Lyon: IARC Press, 2004.
5. Motoi N, Szoke J, Riely GJ, et al. Lung adenocarcinoma: Modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 2008;32:810-827.
6. Kerr KM. Pulmonary adenocarcinomas: Classification and reporting. Histopathology 2009;54:12-27.
7. Chilosi M, Murer B. Mixed adenocarcinomas of the lung: Place in new proposals in classification, mandatory for target therapy. Arch Pathol Lab Med 2010;134:55-65.
8. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006;1:S13-S19. (Pubitemid 47181353)
9. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of the lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-3287. (Pubitemid 46211352)
10. Yousem SA, Beasley MB. Bronchioloalveolar carcinoma: A review of current concepts and evolving issues. Arch Pathol Lab Med 2007;131: 1027-1032. (Pubitemid 47057889)
11. Raz DJ, He B, Rosell R, et al. Current concepts in bronchioloalveolar carcinoma biology. Clin Cancer Res 2006;12:3698-3704. (Pubitemid 44000249)
12. Travis W, Brambilla E, Noguchi M, et al. The New IASLC/ATS/ERS International Multidisciplinary Lung Adenocarcinoma Classification. Presented at the 13th World Lung Cancer Conference, San Francisco, CA, August 2, 2009.
13. Travis WD, Brambilla E, Noguchi M, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011;6:244-285.
14. Yim J, Zhu LC, Chiriboga L, et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol 2007;20:233-241. (Pubitemid 46422178)
15. Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 2009;33:462-469.
16. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: A distinct histologic feature with possible prognostic significance. Am J Surg Pathol 2002;26:358-364. (Pubitemid 34184460)
17. Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003;27:101-109. (Pubitemid 36014903)
18. De Oliveira Duarte Achcar R, Nikiforova MN, Yousem SA. Micropapillary lung adenocarcinoma. EGFR, K-ras, and BRAF mutational profile. Am J Clin Pathol 2009;131:694-700.
19. Casali C, Rossi G, Marchioni A, et al. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: Clinicopathologic analysis, molecular features, and possible pitfalls in routine practice. J Thorac Oncol 2010;5:830-836.
20. Goldstein NS, Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Am J Clin Path 2001;116:319-325. (Pubitemid 32851962)
21. Garfield DH, Cadranel J, West HL. Bronchioloalveolar carcinoma: The case for two diseases. Clin Lung Cancer 2008;9:24-29. (Pubitemid 351251597)
22. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-664.
23. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: Histopathological minimal invasion and prognosis. Am J Surg Pathol 2004;28:198-206. (Pubitemid 38124728)
24. Silver SA, Askin FB. True papillary carcinoma of the lung: A distinct clinicopathologic entity. Am J Surg Pathol 1997;21:43-51.
25. Deshpande CG, Yoshizawa A, Motoi N, et al. Clear cell change in lung adenocarcinoma: A cytologic change rather than a histologic variant. Mod Pathol 2009;22(Suppl 1):1595 (352A).
26. Cohen PR, Yoshizawa A, Motoi N, et al. Signet ring cell features (SRCF) in lung adenocarcinoma: A cytologic feature or a histologic variant? Mod Pathol 2010;23:1787 (400A).
27. Goldstraw P (Ed.), International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology. Orange Park, FL: Editorial Rx Press, 2009.
28. Travis WD, Brambilla E, Rami-Porta R, et al. Visceral pleural invasion: Pathologic criteria and use of elastic stains: Proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008;3:1384-1390.
29. Girard N, Deshpande C, Lau C, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009;33:1752-1764.
30. Kerr KM, Fyfe MN, Nicolson MC, et al. Influence of tumour patterns in mixed-type adenocarcinoma on post-operative survival. J Thorac Oncol 2007;2(Suppl 4):S801-S802.
31. Swerdlow SH, Campo E, Harris NL, et al. World Health Organisation Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed. Lyon, France: IARC Press, 2008.